South Korea
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
51.61%
|
Dec. 31, 2023 | USD 11.90 | 21.74% |
|
South Korea |
|
2 |
28.13%
|
Dec. 31, 2023 | USD 64.45 | 0.31% |
|
South Korea |
|
3 |
21.95%
|
Dec. 31, 2023 | USD 171.86 | 2.57% |
|
South Korea |
|
4 |
21.85%
|
Dec. 31, 2023 | USD 7.40 | 0.83% |
|
South Korea |
|
5 |
18.84%
|
Dec. 31, 2023 | USD 177.66 | 0.74% |
|
South Korea |
|
6 |
18.83%
|
Dec. 31, 2023 | USD 2.05 | 0.07% |
|
South Korea |
|
7 |
18.65%
|
Dec. 31, 2023 | USD 16.03 | -1.15% |
|
South Korea |
|
8 |
17.58%
|
Dec. 31, 2023 | USD 53.54 | 0.36% |
|
South Korea |
|
9 |
17.03%
|
Dec. 31, 2023 | USD 104.35 | -0.50% |
|
South Korea |
|
10 |
16.90%
|
Dec. 31, 2023 | USD 26.12 | -1.82% |
|
South Korea |
|
11 |
15.94%
|
Dec. 31, 2023 | USD 11.69 | 2.23% |
|
South Korea |
|
12 |
15.43%
|
Dec. 31, 2023 | USD 8.62 | 0.98% |
|
South Korea |
|
13 |
14.90%
|
Dec. 31, 2023 | USD 16.27 | 0.32% |
|
South Korea |
|
14 |
14.66%
|
Dec. 31, 2023 | USD 13.23 | 1.89% |
|
South Korea |
|
15 |
13.03%
|
Dec. 31, 2023 | USD 26.36 | -7.63% |
|
South Korea |
|
16 |
12.95%
|
Dec. 31, 2023 | USD 13.98 | -3.04% |
|
South Korea |
|
17 |
11.19%
|
Dec. 31, 2023 | USD 4.13 | 2.75% |
|
South Korea |
|
18 |
11.16%
|
Dec. 31, 2023 | USD 23.19 | 0.44% |
|
South Korea |
|
19 |
11.11%
|
Dec. 31, 2023 | USD 10.59 | -0.10% |
|
South Korea |
|
20 |
10.59%
|
Dec. 31, 2023 | USD 89.82 | -0.84% |
|
South Korea |
|
21 |
10.11%
|
Dec. 31, 2023 | USD 698.37 | 1.93% |
|
South Korea |
|
22 |
9.71%
|
Dec. 31, 2023 | USD 5.07 | 0.47% |
|
South Korea |
|
23 |
9.64%
|
Dec. 31, 2023 | USD 8.29 | 0.57% |
|
South Korea |
|
24 |
9.22%
|
Dec. 31, 2023 | USD 7.02 | 1.13% |
|
South Korea |
|
25 |
9.20%
|
Dec. 31, 2023 | USD 10.03 | -2.25% |
|
South Korea |
|
26 |
8.95%
|
Dec. 31, 2023 | USD 1.83 | 0.74% |
|
South Korea |
|
27 |
8.93%
|
Dec. 31, 2023 | USD 11.51 | 2.62% |
|
South Korea |
|
28 |
8.81%
|
Dec. 31, 2023 | USD 19.95 | 0.05% |
|
South Korea |
|
29 |
8.79%
|
Dec. 31, 2023 | USD 38.12 | 0.02% |
|
South Korea |
|
30 |
8.78%
|
Dec. 31, 2023 | USD 42.83 | 0.90% |
|
South Korea |
|
31 |
8.78%
|
Dec. 31, 2023 | USD 3.84 | 0.74% |
|
South Korea |
|
32 |
8.70%
|
Dec. 31, 2023 | USD 14.32 | 2.94% |
|
South Korea |
|
33 |
7.59%
|
Dec. 31, 2023 | USD 4.37 | 0.43% |
|
South Korea |
|
34 |
7.37%
|
Dec. 31, 2023 | USD 9.53 | 1.69% |
|
South Korea |
|
35 |
7.26%
|
Dec. 31, 2023 | USD 11.90 | 0.22% |
|
South Korea |
|
36 |
7.16%
|
Dec. 31, 2023 | USD 8.54 | 0.34% |
|
South Korea |
|
37 |
7.01%
|
Dec. 31, 2023 | USD 3.25 | 1.59% |
|
South Korea |
|
38 |
6.90%
|
Dec. 31, 2023 | USD 5.78 | -0.09% |
|
South Korea |
|
39 |
6.61%
|
Dec. 31, 2023 | USD 5.79 | -4.44% |
|
South Korea |
|
40 |
6.03%
|
Dec. 31, 2023 | USD 24.38 | 0.88% |
|
South Korea |
|
41 |
5.68%
|
Dec. 31, 2023 | USD 7.36 | 1.21% |
|
South Korea |
|
42 |
5.38%
|
Dec. 31, 2023 | USD 166.75 | 2.20% |
|
South Korea |
|
43 |
5.06%
|
Dec. 31, 2023 | USD 68.20 | 0.14% |
|
South Korea |
|
44 |
4.98%
|
Dec. 31, 2023 | USD 61.65 | 0.74% |
|
South Korea |
|
45 |
4.83%
|
Dec. 31, 2023 | USD 16.30 | -3.69% |
|
South Korea |
|
46 |
4.48%
|
Dec. 31, 2023 | USD 5.50 | 0.24% |
|
South Korea |
|
47 |
4.41%
|
Dec. 31, 2023 | USD 38.94 | 0.04% |
|
South Korea |
|
48 |
4.05%
|
Dec. 31, 2023 | USD 89.21 | -4.31% |
|
South Korea |
|
49 |
3.97%
|
Dec. 31, 2023 | USD 125.83 | 1.12% |
|
South Korea |
|
50 |
3.69%
|
Dec. 31, 2023 | USD 8.31 | 1.99% |
|
South Korea |
The Pharmaceuticals company in South Korea with the highest Return on Capital Employed (ROCE) is Osang Healthcare Co.,Ltd (KOSDAQ: 036220.KQ) at 51.61%.
The Pharmaceuticals company in South Korea with the lowest Return on Capital Employed (ROCE) is Gencurix Inc. (KOSDAQ: 229000.KQ) at -109.25%.
The top 10 Pharmaceuticals companies in South Korea by Return on Capital Employed (ROCE) are Osang Healthcare Co.,Ltd, Chong Kun Dang Pharmaceutical Corp., PharmaResearch Co., Ltd., JW Lifescience Corporation, Hanmi Pharm. Co., Ltd., JW Holdings Corporation, JW Pharmaceutical Corporation, Miwon Chemicals Co., Ltd., Cosmax, Inc. and Humedix Co., Ltd..
The bottom 10 Pharmaceuticals companies in South Korea by Return on Capital Employed (ROCE) are Gencurix Inc., EOFLOW Co.,Ltd., GeneOne Life Science, Inc., Inscobee., Inc., MedPacto, Inc., Helixmith Co., Ltd, PCL, Inc., Peptron, Inc., Oscotec Inc. and Hyundai Bioscience Co., Ltd..